High Vista Strategies LLC Legend Biotech Corp Transaction History

High Vista Strategies LLC

  • $249 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$55.06 - $69.99 $436,075 - $554,320
-7,920 Reduced 17.88%
36,385 $2.04 Million
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $500,227 - $605,880
7,920 Added 21.77%
44,305 $2.98 Million
Q2 2023

Aug 14, 2023
BUY
$46.28 - $75.01 $1.29 Million - $2.1 Million
27,943 Added 331.0%
36,385 $2.51 Million
Q1 2023

May 15, 2023
SELL
$43.42 - $57.37 $337,373 - $445,764
-7,770 Reduced 47.93%
8,442 $407,000
Q4 2022

Feb 14, 2023
BUY
$38.8 - $55.46 $629,025 - $899,117
16,212 New
16,212 $809,000

Others Institutions Holding LEGN

# of Institutions
212
Shares Held
77.9M
Call Options Held
412K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email